LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

Search

MannKind Corp

Cerrado

SectorSanidad

4.59 2

Resumen

Variación precio

24h

Actual

Mínimo

4.5

Máximo

4.61

Métricas clave

By Trading Economics

Ingresos

-12M

668K

Ventas

-1.8M

77M

P/B

Media del Sector

35.455

35.724

Margen de beneficios

0.873

Empleados

403

EBITDA

-17M

9.7M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+105.45% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

5.2M

1.2B

Apertura anterior

2.59

Cierre anterior

4.59

Noticias sobre sentimiento de mercado

By Acuity

15%

85%

22 / 372 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

MannKind Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 ago 2025, 18:43 UTC

Principales Movimientos del Mercado

Privia Health Shares Advance on Outlook Bump From Medicare Savings

29 ago 2025, 15:07 UTC

Adquisiciones, fusiones, absorciones

Strathcona Resources to Increase Minority Stake in MEG Energy, Vote Against Cenovus Buyout Plan

29 ago 2025, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Auto & Transport Roundup: Market Talk

29 ago 2025, 20:24 UTC

Ganancias

Earnings Season Highlights on Tariffs, Consumer Spending, and More -- Barrons.com

29 ago 2025, 20:17 UTC

Ganancias

These Stocks Moved the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 ago 2025, 19:18 UTC

Charlas de Mercado

Oil Futures End Week With Modest Gains -- Market Talk

29 ago 2025, 18:59 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Weekly Gains -- Market Talk

29 ago 2025, 18:36 UTC

Ganancias

These Were the Best & Worst S&P 500 Stocks in August -- Barrons.com

29 ago 2025, 18:26 UTC

Ganancias

What the Stock Market Learned About Earnings and Consumers This Summer -- Barrons.com

29 ago 2025, 17:48 UTC

Charlas de Mercado

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

29 ago 2025, 17:10 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Regulator Firing Clears Path for Union Pacific-Norfolk Southern Deal -- Market Talk

29 ago 2025, 16:57 UTC

Ganancias

These Stocks Are Moving the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 ago 2025, 16:30 UTC

Adquisiciones, fusiones, absorciones

Celsius Stock Is Spiking After PepsiCo Increases Stake -- Barrons.com

29 ago 2025, 16:28 UTC

Adquisiciones, fusiones, absorciones

BBVA: Adjustment Intended to Maintain Equivalent Economic Terms of Offer Following Dividend Payments by Sabadell

29 ago 2025, 16:27 UTC

Adquisiciones, fusiones, absorciones

BBVA: Adjustment Outlined in Announcement on May 9, 2024

29 ago 2025, 16:26 UTC

Adquisiciones, fusiones, absorciones

BBVA Now Offering 1 Newly Issued Ordinary BBVA Share and EUR0.70 in Cash for Every 5.5483 Ordinary Shares of Sabadell

29 ago 2025, 16:25 UTC

Adquisiciones, fusiones, absorciones

BBVA: Adjustment Factors in Interim Dividend Paid by Sabadell to Its Shareholders

29 ago 2025, 16:24 UTC

Adquisiciones, fusiones, absorciones

BBVA Adjusts Offer for Banco de Sabadell

29 ago 2025, 16:23 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Strathcona's Power Play in MEG Energy Jeopardizes Cenovus Deal -- Market Talk

29 ago 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

29 ago 2025, 16:06 UTC

Charlas de Mercado

Gold Futures Gain as U.S. Inflation Data Boost Rate Cut Hopes -- Market Talk

29 ago 2025, 15:12 UTC

Charlas de Mercado
Ganancias

Best Buy Surprise Comp Growth Potentially Driven by Switch 2 -- Market Talk

29 ago 2025, 15:09 UTC

Ganancias

Small-Cap Stocks Are Rallying Again. This Time It's Real. -- Barrons.com

29 ago 2025, 15:01 UTC

Charlas de Mercado

Canadian Economy Expected to Slow But Grow in 2H -- Market Talk

29 ago 2025, 14:49 UTC

Ganancias

These Stocks Are Moving the Most Today: Marvell, Dell, Nvidia, Alibaba, Affirm, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 ago 2025, 14:49 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

29 ago 2025, 14:49 UTC

Charlas de Mercado

Canada May Avoid Contraction in 3Q, But Is Expected to Struggle -- Market Talk

29 ago 2025, 14:48 UTC

Ganancias

Marvell Stock Tumbles. Why the AI Chip Player Keeps Disappointing the Market. -- Barrons.com

29 ago 2025, 14:43 UTC

Charlas de Mercado

Rise in Canadian Household Spending May Not Worry Central Bank -- Market Talk

29 ago 2025, 14:38 UTC

Charlas de Mercado

With Canada's Economy Soft, Central Bank Easing Looks Likely -- Market Talk

Comparación entre iguales

Cambio de precio

MannKind Corp previsión

Precio Objetivo

By TipRanks

105.45% repunte

Estimación a 12 Meses

Media 9.43 USD  105.45%

Máximo 12 USD

Mínimo 7 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para MannKind Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

7 ratings

7

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

4.079 / 4.323Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

22 / 372 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.